143 related articles for article (PubMed ID: 3755716)
1. Studies on the toxicity of RSU-1069.
Whitmore GF; Gulyas S
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1219-22. PubMed ID: 3755716
[TBL] [Abstract][Full Text] [Related]
2. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
Ahmed I; Jenkins TC; Walling JM; Stratford IJ; Sheldon PW; Adams GE; Fielden EM
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1079-81. PubMed ID: 3755711
[TBL] [Abstract][Full Text] [Related]
3. Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
Austen KR; Jenner TJ; O'Neill P; Fielden EM
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):281-8. PubMed ID: 3497125
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the repair and damage of DNA induced by parent and reduced RSU-1069, a 2-nitroimidazole-aziridine.
O'Neill P; Cunniffe SM
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):963-6. PubMed ID: 2649467
[TBL] [Abstract][Full Text] [Related]
5. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
Jenner TJ; O'Neill P; Crump PW; Fielden EM; Sapora O; Santodonato L
Biochem Pharmacol; 1991 Oct; 42(9):1705-10. PubMed ID: 1930296
[TBL] [Abstract][Full Text] [Related]
6. Studies with bifunctional bioreductive drugs. II. Cytotoxicity assayed with A-549 lung carcinoma cells of human origin.
Roizin-Towle L; Pirro JP; Hall EJ
Radiat Res; 1990 Oct; 124(1 Suppl):S50-5. PubMed ID: 2236511
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of DNA damage in mammalian cells upon bioreduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131.
Jenner TJ; Sapora O; O'Neill P; Fielden EM
Biochem Pharmacol; 1988 Oct; 37(20):3837-42. PubMed ID: 3190731
[TBL] [Abstract][Full Text] [Related]
8. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
Hill RP; Gulyas S; Whitmore GF
Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
[TBL] [Abstract][Full Text] [Related]
9. Induction of mutations in V79-4 mammalian cells under hypoxic and aerobic conditions by the cytotoxic 2-nitroimidazole-aziridines, RSU-1069 and RSU-1131. The influence of cellular glutathione.
Sapora O; Paone A; Maggi A; Jenner TJ; O'Neill P
Biochem Pharmacol; 1992 Oct; 44(7):1341-7. PubMed ID: 1417957
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues.
Walling JM; Stratford IJ; Adams GE; Silver AR; Ahmed I; Jenkins TC; Fielden EM
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1083-6. PubMed ID: 3755712
[TBL] [Abstract][Full Text] [Related]
11. The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
Stratford IJ; Walling JM; Silver AR
Br J Cancer; 1986 Mar; 53(3):339-44. PubMed ID: 3754453
[TBL] [Abstract][Full Text] [Related]
12. The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
Keohane A; Godden J; Stratford IJ; Adams GE
Br J Cancer; 1990 May; 61(5):722-6. PubMed ID: 2110815
[TBL] [Abstract][Full Text] [Related]
13. RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.
Adams GE; Ahmed I; Sheldon PW; Stratford IJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1653-6. PubMed ID: 6548211
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of RSU 1069 in spheroids and murine tumors.
Olive PL; Durand RE; Chaplin DJ
Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1361-6. PubMed ID: 3624045
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitizing and cytotoxic effects of nitroimidazoles in CHO cells expressing elevated levels of glutathione-S-transferase.
Stratford IJ; Hickson ID; Robson CN; Stephens M
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1307-10. PubMed ID: 2523884
[TBL] [Abstract][Full Text] [Related]
16. Increased radiosensitivity of aerobic mammalian cells following pre-incubation with misonidazole in hypoxia.
Michaels HB
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1271-4. PubMed ID: 6469749
[TBL] [Abstract][Full Text] [Related]
17. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
Adams GE; Ahmed I; Sheldon PW; Stratford IJ
Br J Cancer; 1984 May; 49(5):571-7. PubMed ID: 6547051
[TBL] [Abstract][Full Text] [Related]
18. The phosphate-group of DNA as a potential target for RSU-1069, a nitroimidazole-aziridine radiosensitizer.
Silver AR; O'Neill P; Jenkins TC; McNeil SS
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1203-6. PubMed ID: 3755715
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo radiosensitizing effects of 2-nitroimidazole derivatives with sugar component.
Murayama C; Tanaka N; Miyamoto Y; Sakaguchi M; Mori T
Strahlenther Onkol; 1987 Jun; 163(6):385-90. PubMed ID: 3603366
[TBL] [Abstract][Full Text] [Related]
20. Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU 1069.
Walling J; Stratford IJ; Adams GE; Stephens MA
Int J Radiat Biol Relat Stud Phys Chem Med; 1988 Apr; 53(4):641-9. PubMed ID: 3258298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
